This site is intended for healthcare professionals only
LoginRegister
Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 croreSanofi concludes acquisition of Vicebio
Merck in Talks to Acquire Revolution Medicines in USD 28-32 Billion Oncology DealMerck division gets USFDA conditional approval for Exzolt Cattle-CA1 against cattle fever tick
Takeda announces closing of partnership with Innovent Biologics for oncology medicinesTakeda announces closing of partnership with Innovent Biologics for oncology medicines
Bayer Finerenone approved in Japan for chronic heart failureBayer begins Phase IIa trial of BAY 3401016 for Alport Syndrome
WHO Alert Spurs Indias Probe Into Deadly Cough Syrup, Licence Cancelled, 700 Plus Units Audited, Parliament InformedWHO Alert Spurs India's Probe Into Deadly Cough Syrup, Licence Cancelled, 700 Plus Units Audited,...
CDSCO Panel Seeks Protocol Revisions in Levim Lifetechs Teriparatide Biosimilar StudyCDSCO Panel Seeks Protocol Revisions in Levim Lifetech's Teriparatide Biosimilar Study
Antibiotics May Soon Carry Blue Strip as Health Ministry Moves to Fight AMRSame Brand Name Used for Multiple Drugs: Govt Panel Calls for Stakeholder Consultation
Over 4000 medical device manufacturing sites licensed since 2021, Minister tells ParliamentOver 4000 medical device manufacturing sites licensed since 2021, Minister tells Parliament
CDSCO Expert Panel Accepts Phase IV Safety Data for Eisai Pharmas Lenvatinib CapsulesProduct basket under Pradhan Mantri Bhartiya Janaushadhi Yojna has 2110 medicines: Minister
Biocon Secures Rs 4,150 Cr Through QIP to Buy Out Viatris Stake in Biologics ArmBiocon to make Biocon Biologics a wholly owned arm
Senores PharmaSenores Pharma gets Philippine FDA approval for basket of 10 products
Biocon Secures Rs 4,150 Cr Through QIP to Buy Out Viatris Stake in Biologics ArmBiocon Pharma gains tentative USFDA nod for Parkinson's disease capsules
X